INSYS Therapeutics, Inc., a specialty pharmaceutical company, has recently signed a lease to move its headquarters to Chandler from Phoenix.
INSYS will move to the Chandler 101 Business Center, located in the Price Corridor.
The company focuses on developing and commercializing products that address chemotherapy-induced nausea and vomiting (CINV), pain management and other central nervous system disorders. The US Food and Drug Administration recently approved its cancer pain medication, SUBSYS fentanyl sublingual spray.
